{"id":23430,"date":"2025-04-13T17:39:45","date_gmt":"2025-04-13T17:39:45","guid":{"rendered":"https:\/\/researchchemicalhub.com\/?post_type=product&#038;p=23430"},"modified":"2025-10-30T09:39:53","modified_gmt":"2025-10-30T09:39:53","slug":"4-aco-mipt-fumarate","status":"publish","type":"product","link":"https:\/\/researchchemicalhub.com\/is\/shop\/4-aco-mipt\/4-aco-mipt-fumarate\/","title":{"rendered":"4-AcO-MiPT f\u00famarat"},"content":{"rendered":"<h3><strong>4-AcO-MiPT f\u00famarat \u2013 V\u00f6rul\u00fdsing, notkun, \u00e1vinningur og gallar og algengar spurningar<\/strong><\/h3>\n<h4><strong>\ud83d\udd2c V\u00f6rul\u00fdsing<\/strong><\/h4>\n<p class=\"ds-markdown-paragraph\">4-AcO-MiPT (4-asetox\u00fd-N-met\u00fdl-N-\u00eds\u00f3pr\u00f3p\u00fdltryptam\u00edn) f\u00famarat er tilb\u00fai\u00f0 tryptam\u00edn sem er skyld efnum eins og psilocin (4-HO-DMT) og 4-AcO-DMT. \u00deetta er ranns\u00f3knarefni sem veri\u00f0 er a\u00f0 rannsaka vegna einstakra ge\u00f0virkra eiginleika \u00feess og m\u00f6gulegra notkunarm\u00f6guleika \u00ed taugav\u00edsindum.<\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Efnaheiti:<\/strong>\u00a04-asetox\u00fd-N-met\u00fdl-N-\u00eds\u00f3pr\u00f3p\u00fdltryptam\u00edn f\u00famarat<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Sameindaform\u00fala:<\/strong>\u00a0C\u2081\u2087H\u2082\u2084N\u2082O\u2082 \u00b7 C\u2084H\u2084O\u2084<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Sameindamassi:<\/strong>\u00a0388,43 g\/m\u00f3l<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>\u00datlit:<\/strong>\u00a0Hv\u00edtt til lj\u00f3sbr\u00fant kristalla\u00f0 duft<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Hreinleiki:<\/strong>\u00a0\u226598% (sta\u00f0fest me\u00f0 HPLC og GC\/MS greiningu)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Leysni:<\/strong>\u00a0Leysanlegt \u00ed vatni, metan\u00f3li og etan\u00f3li<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h3><strong>\ud83d\udca1 Notkunarsvi\u00f0smyndir af 4-AcO-MiPT f\u00famarati<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">4-AcO-MiPT f\u00famarat er\u00a0<strong>eing\u00f6ngu \u00e6tla\u00f0 til v\u00edsindaranns\u00f3kna<\/strong>\u00a0og ekki til manneldis. M\u00f6guleg notkun er me\u00f0al annars:<\/p>\n<ol start=\"1\">\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>S\u00e1lfr\u00e6\u00f0ilegar lyfjafr\u00e6\u00f0ilegar ranns\u00f3knir<\/strong>\u00a0\u2013 Ranns\u00f3kn \u00e1 ser\u00f3t\u00f3n\u00ednvirkum \u00e1hrifum (5-HT\u2082A) og breytingum \u00e1 skynjun.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Samanbur\u00f0argreining<\/strong>\u00a0\u2013 Ranns\u00f3knir \u00e1 muninum \u00e1 tryptam\u00ednaflei\u00f0um (t.d. 4-AcO-DMT vs. 4-AcO-MiPT).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>D\u00fdraranns\u00f3knir (\u00ed st\u00fdr\u00f0u umhverfi)<\/strong>\u00a0\u2013 Athugun \u00e1 atferlis- og taugafr\u00e6\u00f0ilegum \u00e1hrifum.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Ranns\u00f3knir \u00e1 bindingu vi\u00f0taka<\/strong>\u00a0\u2013 In vitro pr\u00f3fanir \u00e1 milliverkunum vi\u00f0 ser\u00f3t\u00f3n\u00edn og \u00f6nnur taugabo\u00f0efnakerfi.<\/p>\n<\/li>\n<\/ol>\n<hr \/>\n<h3><strong>\u26a0\ufe0f \u00d3kostir og \u00e1h\u00e6tta<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>S\u00e1lfr\u00e6\u00f0ileg \u00e1hrif<\/strong>\u00a0\u2013 Getur valdi\u00f0 ofskynjunum ef \u00fea\u00f0 er nota\u00f0 \u00e1 rangan h\u00e1tt.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>\u00d3fullkomnar uppl\u00fdsingar um eitur\u00e1hrif<\/strong>\u00a0\u2013 Langt\u00edma\u00f6ryggi er ekki a\u00f0 fullu \u00feekkt.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>N\u00e1kv\u00e6mur skammtur nau\u00f0synlegur<\/strong>\u00a0\u2013 L\u00e1gir skammtar (5-15 mg) geta \u00feegar haft sterk \u00e1hrif.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>M\u00f6gulegar aukaverkanir<\/strong>\u00a0\u2013 Kv\u00ed\u00f0i, rugl, \u00f3gle\u00f0i e\u00f0a hra\u00f0sl\u00e1ttur.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>L\u00f6gleg sta\u00f0a<\/strong>\u00a0\u2013 L\u00f6g um notkun \u00ed sumum l\u00f6ndum (athugi\u00f0 gildandi l\u00f6g).<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h3><strong>\ud83d\udcca R\u00e1\u00f0lag\u00f0ur skammtur (eing\u00f6ngu til ranns\u00f3kna)<\/strong><\/h3>\n<div class=\"markdown-table-wrapper\">\n<table>\n<thead>\n<tr>\n<th>Ums\u00f3kn<\/th>\n<th>Skammtur (mg)<\/th>\n<th>Leysiefni<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Ranns\u00f3knir in vitro<\/td>\n<td>1-5<\/td>\n<td>Eima\u00f0 vatn \/ etan\u00f3l<\/td>\n<\/tr>\n<tr>\n<td>D\u00fdratilraunir*<\/td>\n<td>0,1-0,3 mg\/kg<\/td>\n<td>L\u00edfe\u00f0lisfr\u00e6\u00f0ileg saltlausn<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\">*Alltaf framkv\u00e6mt innan si\u00f0fer\u00f0ilega vi\u00f0urkennds ranns\u00f3knarramma.<\/p>\n<hr \/>\n<h3><strong>\u2753 Algengar spurningar (FAQs)<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\"><strong>1. Er 4-AcO-MiPT l\u00f6glegt \u00ed Hollandi?<\/strong><br \/>\n\u00dea\u00f0 g\u00e6ti falli\u00f0 undir\u00a0<strong>\u00d3p\u00eduml\u00f6gin<\/strong>, allt eftir t\u00falkun. Leiti\u00f0 r\u00e1\u00f0a hj\u00e1 l\u00f6gfr\u00e6\u00f0ingi til frekari ranns\u00f3knar.<\/p>\n<p class=\"ds-markdown-paragraph\"><strong>2. Hvernig er \u00fea\u00f0 fr\u00e1brug\u00f0i\u00f0 4-AcO-DMT?<\/strong><br \/>\n4-AcO-MiPT hefur \u00f6rl\u00edti\u00f0 mildari og \u201eloftmeiri\u201c upplifun samanbori\u00f0 vi\u00f0 4-AcO-DMT, me\u00f0 hugsanlega meiri skynjunarb\u00e6tingu.<\/p>\n<p class=\"ds-markdown-paragraph\"><strong>3. Hvernig \u00e6tti a\u00f0 geyma \u00fea\u00f0?<\/strong><br \/>\nGeymi\u00f0 \u00ed\u00a0<strong>loft\u00fe\u00e9tt, d\u00f6kk \u00edl\u00e1t<\/strong>vi\u00f0 hitastig undir 25\u00b0C og vari\u00f0 gegn raka.<\/p>\n<p class=\"ds-markdown-paragraph\"><strong>4. Eru einhverjar h\u00e6ttulegar milliverkanir til sta\u00f0ar?<\/strong><br \/>\nJ\u00e1, for\u00f0astu samsetningar me\u00f0\u00a0<strong>MAO-hemlar, SSRI-lyf, \u00f6rvandi lyf<\/strong>\u00a0og \u00f6nnur ser\u00f3t\u00f3n\u00ednvirk efni (h\u00e6tta af v\u00f6ldum ser\u00f3t\u00f3n\u00ednr\u00e6ma).<\/p>\n<p class=\"ds-markdown-paragraph\"><strong>5. Er ranns\u00f3knarsk\u00fdrsla tilt\u00e6k?<\/strong><br \/>\nJ\u00e1, vi\u00f0 kaup \u00e1\u00a0<strong>COA (greiningarvottor\u00f0)<\/strong>\u00a0me\u00f0 HPLC og massagreiningarg\u00f6gnum.<\/p>\n<hr \/>\n<h3><strong>\ud83d\udd0e Ni\u00f0ursta\u00f0a<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">4-AcO-MiPT f\u00famarat er \u00e1hugavert ranns\u00f3knarefni me\u00f0 m\u00f6guleika \u00e1 v\u00edsindalegum notkunum, en vegna ge\u00f0virkra eiginleika \u00feess ver\u00f0ur \u00fea\u00f0 a\u00f0 vera ...\u00a0<strong>a\u00f0eins vi\u00f0 st\u00fdr\u00f0ar ranns\u00f3knarstofua\u00f0st\u00e6\u00f0ur<\/strong>\u00a0eru notu\u00f0.<\/p>\n<p class=\"ds-markdown-paragraph\">\u26a0\ufe0f\u00a0<strong>Mikilv\u00e6gt:<\/strong>\u00a0\u00deessi vara er\u00a0<strong>ekki til manneldis<\/strong>\u00a0og ver\u00f0ur a\u00f0 me\u00f0h\u00f6ndla me\u00f0 var\u00fa\u00f0.<\/p>","protected":false},"excerpt":{"rendered":"<h3>4-AcO-MiPT fumarate eigenschappen<\/h3>\n<p><strong>Synoniem:<\/strong> 4-acetoxy-N-methyl-N-isopropyltryptamine fumarate<br \/>\n<strong>CAS Nummer:<\/strong> 1024612-25-6<br \/>\n<strong>Formule:<\/strong> 3-[2-(methyl(isopropyl)amino)ethyl]-1H-indol-4-yl acetate fumarate<br \/>\n<strong>Molmassa:<\/strong> 390.4 g\/mol<br \/>\n<strong>Zuiverheid:<\/strong> &gt;97%<\/p>\n","protected":false},"featured_media":28424,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[538,381],"product_tag":[1206,1207,326],"class_list":{"0":"post-23430","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-4-aco-mipt","7":"product_cat-tryptamines","8":"product_tag-4-aco-mipt-fumarate","9":"product_tag-4-aco-mipt-fumarate-kopen","10":"product_tag-nl","12":"first","13":"instock","14":"taxable","15":"shipping-taxable","16":"purchasable","17":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product\/23430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/comments?post=23430"}],"version-history":[{"count":4,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product\/23430\/revisions"}],"predecessor-version":[{"id":26538,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product\/23430\/revisions\/26538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/media\/28424"}],"wp:attachment":[{"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/media?parent=23430"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product_brand?post=23430"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product_cat?post=23430"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalhub.com\/is\/wp-json\/wp\/v2\/product_tag?post=23430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}